SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-17-001109
Filing Date
2017-02-03
Accepted
2017-02-03 21:19:53
Documents
1
Period of Report
2017-02-01

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3977
  Complete submission text file 0001493152-17-001109.txt   5619
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address
SAHAREK JOHN P. (Reporting) CIK: 0001632091 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 17573945